KESTREL INVESTMENT MANAGEMENT CORP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 170 filers reported holding HAEMONETICS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
KESTREL INVESTMENT MANAGEMENT CORP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2016$5,922,000
+6.8%
169,300
-1.6%
2.28%
+3.0%
Q4 2015$5,545,000
-13.4%
172,000
-13.2%
2.22%
-0.7%
Q3 2015$6,404,000
-22.8%
198,150
-1.2%
2.23%
-12.9%
Q2 2015$8,299,000
-53.5%
200,650
-49.5%
2.56%
+5.0%
Q1 2015$17,862,000
+16.5%
397,650
-2.9%
2.44%
+19.5%
Q4 2014$15,329,000
+4.9%
409,650
-2.1%
2.04%
-1.2%
Q3 2014$14,616,000
-4.3%
418,550
-3.3%
2.07%
+8.7%
Q2 2014$15,278,000
+6.2%
433,050
-1.9%
1.90%
+6.6%
Q1 2014$14,380,000
-24.6%
441,250
-2.5%
1.78%
-23.9%
Q4 2013$19,060,000
-13.0%
452,400
-17.6%
2.34%
+4.1%
Q3 2013$21,902,000
-5.3%
549,200
-1.8%
2.25%
-12.2%
Q2 2013$23,127,000559,3002.56%
Other shareholders
HAEMONETICS CORP shareholders Q3 2015
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders